Expect to See Med Changes in Pregnant Women With Thyroid Disease

November 2018

Uncontrolled thyroid disease during pregnancy has risks...such as miscarriage, preterm birth, low birth weight, and cognitive defects.

Consider these tips to limit adverse fetal outcomes when these patients are admitted.

HYPOthyroidism. For newly pregnant patients, increase the maintenance levothyroxine by about 25% to 30% if it wasn't already done by the outpatient prescriber. Pregnant women need higher levothyroxine doses...because of faster drug metabolism, T4 transfer to the baby, etc.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Learn More

Already a subscriber? Log in

Not sold to individuals

Renal & Urology Know Which Patients Are Prone to Faster Renal Clearance
Critical Care Check Med Dosing During Extracorporeal Membrane Oxygenation (ECMO)
Hematology & Oncology Safely Transition Patients on Chronic Immune Thrombocytopenia Meds at Home
Endocarditis Emphasize Adherence in Endocarditis Patients Discharged on Oral Antibiotics
Diabetes Meds Act Fast When You Suspect Fournier's Gangrene Due to a Flozin
Men's Health Lean Toward Oral TMP/SMX Over Quinolones to Treat Acute Bacterial Prostatitis
Aspirin Anticipate Less Use of Aspirin for Primary Prevention of CV Disease
Pregnancy Expect to See Med Changes in Pregnant Women With Thyroid Disease
New Drugs Lean Away From the New ZTlido Rx Lidocaine Patch

Expect to See Med Changes in Pregnant Women With Thyroid Disease

Get unlimited access through an Enterprise license

Table of Contents